Phase II Trial of Moxifloxacin for Tb

Chaisson, Richard E.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Food and Drug Administration (FDA)
• Type: Research Project (R01)
• Project #: 3R01FD002135-03S1
• Application #: 7448527
• Study Section: Special Emphasis Panel (ZFD1-SRC (99))
• Program Officer: Ganti, Usha
• Project Start: 2003-09-30
• Project End: 2008-04-30
• Budget Start: 2006-05-01
• Budget End: 2008-04-30
• Support Year: 3
• Fiscal Year: 2007

Institution

• Name: Johns Hopkins University
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 001910777
• City: Baltimore
• State: MD
• Country: United States
• Zip Code: 21218

Publications

Conde, Marcus B; Efron, Anne; Loredo, Carla et al. (2009) Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 373:1183-9